Estimating the optimal perioperative chemotherapy utilization rate for muscle‐invasive bladder cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Estimating the optimal perioperative chemotherapy utilization rate for muscle‐invasive bladder cancer

Published:2019-08-31 Issue:14 Volume:8 Page:6258-6271
ISSN:2045-7634
Container-title:Cancer Medicine
language:en
Short-container-title:Cancer Med

Author:

Karim Safiya¹^ORCID,Mackillop William J.²³⁴,Brennan Kelly⁴,Peng Yingwei³⁴,Siemens D. Robert⁵,Krzyzanowska Monika K.⁶,Booth Christopher M.²³⁴

Affiliation:

1. Department of Oncology Tom Baker Cancer Centre University of Calgary Calgary Canada

2. Department of Oncology Queen's University Kingston Canada

3. Department of Public Health Sciences Queen's University Kingston Canada

4. Division of Cancer Care and Epidemiology Queen's University Cancer Research Institute Kingston Canada

5. Department of Urology Queen's University Kingston Canada

6. Division of Medical Oncology & Hematology Princess Margaret Cancer Centre Toronto Canada

Funder

Canada Foundation for Innovation

Canadian Cancer Society Research Institute

Publisher

Wiley

Subject

Cancer Research,Radiology, Nuclear Medicine and imaging,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cam4.2449

Reference27 articles.

1. Perioperative chemotherapy for muscle-invasive bladder cancer: A population-based outcomes study

2. Neoadjuvant Chemotherapy plus Cystectomy Compared with Cystectomy Alone for Locally Advanced Bladder Cancer

3. International Phase III Trial Assessing Neoadjuvant Cisplatin, Methotrexate, and Vinblastine Chemotherapy for Muscle-Invasive Bladder Cancer: Long-Term Results of the BA06 30894 Trial

4. Neoadjuvant Chemotherapy in Invasive Bladder Cancer: Update of a Systematic Review and Meta-Analysis of Individual Patient Data

5. Adjuvant Chemotherapy in Invasive Bladder Cancer: A Systematic Review and Meta-Analysis of Individual Patient Data

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Low adherence to recommended use of neoadjuvant chemotherapy for muscle-invasive bladder cancer;World Journal of Urology;2023-05-31

2. Building the Canadian Bladder Cancer Research Network (CBCRN): Progress During a Pandemic;Canadian Urological Association Journal;2022-02-15

3. Current Perioperative Therapy for Muscle Invasive Bladder Cancer;Hematology/Oncology Clinics of North America;2021-06

4. Current Management of Localized Muscle-Invasive Bladder Cancer: A Consensus Guideline from the Genitourinary Medical Oncologists of Canada;Bladder Cancer;2020-09-21

5. Trimodality Therapy for Muscle-Invasive Bladder Cancer: Concurrent Chemotherapy is Not Enough;Journal of Clinical Oncology;2020-08-20

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3